Crossr

Crossr
The Crossr platform allows scientists in pharmaceutical and biotechnology companies to analyse biomedical knowledge graphs and run ML pipelines, without needing to know any code. This allows them to identify genes and proteins of importance in disease states and develop precision medicines with better efficacy and safety profiles. The platform reduces hypothesis to insight cycle times 100X and can save the average pharmaceutical company 10,000s of hours of scientist time and £1 millions in costs.
Business Highlights
lock
Video
lock
Investment Deck
lock
Team
lock

03Other opportunities

SFC Angel Fund XIII SEIS

SFC Angel Fund XIII SEIS

Invest under SEIS in high potential start-ups.
Fund Size £50m SEIS
SFC Angel Fund XI EIS

SFC Angel Fund XI EIS

Invest in SFC’s portfolio stars.
Fund Size £20m EIS

Help me stop

Help Me Stop is pioneering day treatment for alcohol and drug addic ...
Raising TBD EIS

XeroE

Sustainable, emission-free deliveries marketplace
Raising TBD EIS